4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018316
See Remarks bought 400 shares at $15.00 ($6,000)
- See Remarks acquired 47,396 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GARDNER JASON See Remarks | 2018-06-25 | Conversion | +25,719 | 292,990 | I | ||
| GARDNER JASON See Remarks | 2018-06-25 | Conversion | +21,677 | 359,092 | I | ||
| GARDNER JASON See Remarks | 2018-06-25 | Purchase | +400 | $15.00 | $6,000 | 363,212 | D |
| Derivatives | |||||||
| GARDNER JASON See Remarks | 2018-06-25 | Conversion · Series A Preferred Stock | −30,000 | 0 | I | ||
| GARDNER JASON See Remarks | 2018-06-25 | Conversion · Series A Preferred Stock | −36,700 | 0 | I | ||
| GARDNER JASON See Remarks | 2018-06-25 | Conversion · Series B Preferred Stock | −15,000 | 0 | I | ||
| GARDNER JASON See Remarks | 2018-06-25 | Conversion · Series B Preferred Stock | −19,314 | 0 | I | ||
| GARDNER JASON See Remarks | 2018-06-25 | Conversion · Series C Preferred Stock | −21,459 | 0 | I | ||
| Open-market purchases · 400 sh · avg $15.00 · $6,000 | |||||||
Loading xslF345X03/doc4.xml…